Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orchard Therapeutics Ltd.

www.orchard-tx.com

Latest From Orchard Therapeutics Ltd.

Tech Transfer Roundup: OncoSec Will Investigate CAR-T In Breast Cancer With Dana-Farber

Building on research by Dana-Farber professor Wayne Marasco, the partners are backing a bispecific approach to CAR-Ts in solid tumors. Seelos licenses a Parkinson’s gene therapy candidate from Duke.

Deals Business Strategies

EMA Discusses Pivotal Role Of RWE For Six Drugs

The European Medicines Agency explains how it used real-word evidence during recent deliberations for six products. 
Europe Drug Approval Standards

Orchard Plans EU Submission For GSK-Originated MLD Gene Therapy

Orchard is aiming to get its second autologous gene therapy on the market next year, with a European filing for MLD and a BLA to follow.

Gene Therapy Rare Diseases

Oxford Biomedica, Microsoft Pact Aims At Better, Cheaper Lentiviral Vectors

Oxford Biomedica and Microsoft have joined forces to improve the yield and quality of next-generation gene therapy vectors using the cloud and machine learning, the UK gene and cell therapy company's chief business officer tells Scrip.

Artificial Intelligence Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Immune Disorders
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Orchard Therapeutics Ltd.
  • Senior Management
  • Mark Rothera, Pres. & CEO
    Frank Thomas, CFO & CBO
    Andrea Spezzi, MD, CMO
    Bobby Gaspar, MD, CSO
    Adrien Lemoine, SVP, Bus. Dev. & Alliance Mgmt.
  • Contact Info
  • Orchard Therapeutics Ltd.
    Phone: 203 384 6700
    108 Cannon St.
    London, EC4N 6EU
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register